AB Science S.A. (FRA:A8D)
Germany
· Delayed Price · Currency is EUR 1.184
+0.030 (2.60%)
At close: Dec 5, 2025
AB Science Statistics
Total Valuation
AB Science has a market cap or net worth of EUR 88.70 million. The enterprise value is 102.75 million.
| Market Cap | 88.70M |
| Enterprise Value | 102.75M |
Important Dates
The next estimated earnings date is Thursday, May 7, 2026.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 66.18M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.43% |
| Shares Change (QoQ) | +6.32% |
| Owned by Insiders (%) | 6.20% |
| Owned by Institutions (%) | 0.00% |
| Float | 59.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 86.37 |
| PB Ratio | -3.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.03 |
| EV / Sales | 100.05 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.51 |
Financial Position
The company has a current ratio of 0.67
| Current Ratio | 0.67 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.69 |
| Interest Coverage | -4.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -14.79% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -184.71% |
| Revenue Per Employee | 28,528 |
| Profits Per Employee | -237,194 |
| Employee Count | 39 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +60.43% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +60.43% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.29 |
| Relative Strength Index (RSI) | 51.59 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AB Science had revenue of EUR 1.03 million and -8.54 million in losses. Loss per share was -0.15.
| Revenue | 1.03M |
| Gross Profit | 932,000 |
| Operating Income | -5.23M |
| Pretax Income | -8.54M |
| Net Income | -8.54M |
| EBITDA | -4.71M |
| EBIT | -5.23M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 5.03 million in cash and 19.08 million in debt, giving a net cash position of -14.05 million.
| Cash & Cash Equivalents | 5.03M |
| Total Debt | 19.08M |
| Net Cash | -14.05M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -27.32M |
| Book Value Per Share | -0.41 |
| Working Capital | -6.07M |
Cash Flow
In the last 12 months, operating cash flow was -6.88 million and capital expenditures -203,000, giving a free cash flow of -7.08 million.
| Operating Cash Flow | -6.88M |
| Capital Expenditures | -203,000 |
| Free Cash Flow | -7.08M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 90.75% |
| Operating Margin | -509.15% |
| Pretax Margin | -831.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AB Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.43% |
| Shareholder Yield | -9.43% |
| Earnings Yield | -9.63% |
| FCF Yield | -7.98% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |